Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic is a global leader in medical technology, developing and manufacturing innovative medical devices and offering advanced therapies to improve healthcare and patient quality of life. Key business areas include Cardiovascular, Diabetes, Neuroscience, and Minimally Invasive Surgery.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic (MDT) reported its Q2 2026 financial results on September 1, 2026, before the market open. The company reported earnings per share (EPS) of 1.45 USD, beating the analyst estimate of 1.39 USD by 4.4%. Revenue for the quarter reached 9756 million USD. Following the release, the stock price rose by 1.53%.
Generated automatically from our data — as of 09/09/2026 Read the article →
Medtronic is scheduled to report its next quarterly earnings on 11/24/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic last reported quarterly earnings on 9/1/2026 (Q2 2026). Earnings per share (EPS) came in at 1.45 USD.
Across its last 4 earnings reports, Medtronic stock moved by ±3.8% on average the following day. The largest reaction was +5.7% on 06/03/2026; 3 of 4 reactions were positive.
Medtronic has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.